International multicenter examination of MOG antibody assays

International multicenter examination of MOG antibody assays

<p><strong>Objective</strong> To compare the reproducibility of 11 antibody assays for immunoglobulin (Ig) G and IgM myelin oligodendrocyte glycoprotein antibodies (MOG-IgG and MOG-IgM) from 5 international centers.</p> <p><strong>Methods</strong> The follo...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Reindl, M, Schanda, K, Woodhall, M, Ramberger, M, Leite, MI, Palace, J, Irani, SR, Waters, P
Natura:	Journal article
Lingua:	English
Pubblicazione:	Lippincott, Williams and Wilkins 2020

Documenti analoghi

An international multicentre validation experiment for MOG antibodies
di: Reindl, M, et al.
Pubblicazione: (2018)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
di: Pace, S, et al.
Pubblicazione: (2021)

A multicenter comparison of MOG-IgG cell-based assays
di: Waters, P, et al.
Pubblicazione: (2019)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
di: Waters, P, et al.
Pubblicazione: (2015)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
di: Jurynczyk, M, et al.
Pubblicazione: (2016)

Recurrent optic neuritis associated with MOG antibody seropositivity
di: Chang, T, et al.
Pubblicazione: (2017)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
di: Elsone, L, et al.
Pubblicazione: (2014)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
di: Waters, P, et al.
Pubblicazione: (2015)

Disease course and disability outcomes in MOG-antibody disease in the UK
di: Jurynczyk, M, et al.
Pubblicazione: (2017)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.
di: Morris, K, et al.
Pubblicazione: (2015)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
di: Jurynczyk, M, et al.
Pubblicazione: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
di: Jurynczyk, M, et al.
Pubblicazione: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
di: Jurynczyk, M, et al.
Pubblicazione: (2017)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
di: Waters, P, et al.
Pubblicazione: (2016)

We need to talk about MOG
di: Waters, P, et al.
Pubblicazione: (2020)

MOG-IgA as a potential marker of germinal center activity
di: Handel, AE, et al.
Pubblicazione: (2024)

No strong HLA association with MOG antibody disease in the UK population
di: Grant-Peters, M, et al.
Pubblicazione: (2021)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
di: Jarius, S, et al.
Pubblicazione: (2018)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
di: Juryńczyk, M, et al.
Pubblicazione: (2016)

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
di: Kim, Y, et al.
Pubblicazione: (2020)

MOG-IgG1 antibodies in children
di: Waters, P, et al.
Pubblicazione: (2018)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
di: Maciej Jurynczyk, et al.
Pubblicazione: (2017-12-01)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
di: Yeo, T, et al.
Pubblicazione: (2020)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
di: Whittam, DH, et al.
Pubblicazione: (2020)

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
di: Kaneko, K, et al.
Pubblicazione: (2016)

Predictors of relapse in MOG antibody associated disease: a cohort study
di: Saif Huda, et al.
Pubblicazione: (2021-11-01)

Prospective clinical and MRI characterization of children with serum anti-MOG antibodies meeting the multiple sclerosis diagnostic criteria
di: Fadda, G, et al.
Pubblicazione: (2018)

No strong HLA association with MOG antibody disease in the UK population
di: Melissa Grant‐Peters, et al.
Pubblicazione: (2021-07-01)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
di: Hyun, J, et al.
Pubblicazione: (2018)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
di: Sara Mariotto, et al.
Pubblicazione: (2017-10-01)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
di: Sato, D, et al.
Pubblicazione: (2014)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
di: Tianrong Yeo, et al.
Pubblicazione: (2020-03-01)

Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay.
di: Melanie Ramberger, et al.
Pubblicazione: (2015-01-01)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
di: Sato, D, et al.
Pubblicazione: (2014)

Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders
di: Rinaldi, S, et al.
Pubblicazione: (2020)

Peripheral nervous system involvement in MOG antibody-associated demyelination
di: Ramanathan, S, et al.
Pubblicazione: (2019)

MOG antibody associated disorder (MOGAD)
di: Lilley Kate, et al.
Pubblicazione: (2021-01-01)

Epilepsy in patients with MOG antibody disease
di: Varvara E. Avdeeva, et al.
Pubblicazione: (2021-10-01)

Teratoma-derived glycine receptor antibodies in progressive encephalomyelitis with rigidity and myoclonus
di: Sun, B, et al.
Pubblicazione: (2019)

Anti-MOG Antibody Seropositive Patient Successfully Treated with Intermittent Rituximab Infusion
di: Kim, W, et al.
Pubblicazione: (2014)